Davalos V, Esteller M. Cancer epigenetics in clinical practice. CA: A Cancer J Clin. 2023;73(4):376–424.

Google Scholar 

Foo J, et al. Roadmap on plasticity and epigenetics in cancer. Phys Biol. 2022;19(3):031501.

Google Scholar 

Lee JE, Kim M-Y. Cancer epigenetics: past, present and future. In: Vincent T, editor. Seminars in cancer biology. Amsterdam: Elsevier; 2022.

Google Scholar 

Gu M, et al. Epigenetic regulation in cancer. MedComm. 2024;5(2):e495.

PubMed  PubMed Central  Google Scholar 

Patnaik E, Madu C, Lu Y. Epigenetic modulators as therapeutic agents in cancer. Int J Mol Sci. 2023;24(19):14964.

PubMed  PubMed Central  Google Scholar 

Banerjee R, et al. Epigenetic basis and targeting of cancer metastasis. Trends in Cancer. 2022;8(3):226–41.

PubMed  Google Scholar 

Biswas S, Rao CM. Epigenetics in cancer: fundamentals and beyond. Pharmacol Ther. 2017;173:118–34.

PubMed  Google Scholar 

Neganova ME, et al. Histone modifications in epigenetic regulation of cancer: perspectives and achieved progress. In: Vincent T, editor., et al., Seminars in cancer biology. Amsterdam: Elsevier; 2022.

Google Scholar 

Bennett RL, Licht JD. Targeting epigenetics in cancer. Annu Rev Pharmacol Toxicol. 2018;58:187–207.

PubMed  Google Scholar 

Park JW, Han J-W. Targeting epigenetics for cancer therapy. Arch Pharmacal Res. 2019;42:159–70.

Google Scholar 

Costa PMDS, et al. Epigenetic reprogramming in cancer: from diagnosis to treatment. Front Cell Dev Biol. 2023;11:1116805.

PubMed  PubMed Central  Google Scholar 

Hojjatipour T, Maali A, Azad M. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy. Epigenomics. 2023;15(4):249–66.

PubMed  Google Scholar 

Xiong S, Feng Y, Cheng L. Cellular reprogramming as a therapeutic target in cancer. Trends Cell Biol. 2019;29(8):623–34.

PubMed  Google Scholar 

Xu Y, et al. Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials. Cancer Commun. 2022;42(6):493–516.

Google Scholar 

Maleszewska M, Wojtas B, Kamińska B. Deregulation of epigenetic mechanisms in cancer. Postepy Biochem. 2018;64(2):148–56.

PubMed  Google Scholar 

Klinge CM. Non-coding RNAs: long non-coding RNAs and microRNAs in endocrine-related cancers. Endocr Relat Cancer. 2018;25(4):R259–82.

PubMed  Google Scholar 

Mohammad HP, Barbash O, Creasy CL. Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer. Nat Med. 2019;25(3):403–18.

PubMed  Google Scholar 

Kumar D, et al. Decoding the function of bivalent chromatin in development and cancer. Genome Res. 2021;31(12):2170–84.

PubMed  PubMed Central  Google Scholar 

Ravi N, et al. Global RNA expression and DNA methylation patterns in primary anaplastic thyroid cancer. Cancers. 2020;12(3):680.

PubMed  PubMed Central  Google Scholar 

Dobre M, et al. Crosstalk between DNA methylation and gene mutations in colorectal cancer. Front Oncol. 2021;11:697409.

PubMed  PubMed Central  Google Scholar 

Ilango S, et al. Epigenetic alterations in cancer. Front Biosci-Landmark. 2020;25(6):1058–109.

Google Scholar 

Zafon C, et al. DNA methylation in thyroid cancer. Endocr Relat Cancer. 2019;26(7):R415–39.

PubMed  Google Scholar 

Brägelmann J, et al. Epigenome-wide analysis of methylation changes in the sequence of gallstone disease, dysplasia, and gallbladder cancer. Hepatology. 2021;73(6):2293–310.

PubMed  Google Scholar 

Otmani K, Lewalle P. Tumor suppressor miRNA in cancer cells and the tumor microenvironment: mechanism of deregulation and clinical implications. Front Oncol. 2021;11:708765.

PubMed  PubMed Central  Google Scholar 

Hatam S. MicroRNAs improve cancer treatment outcomes through personalized medicine. Microrna. 2023;12(2):92–8.

PubMed  Google Scholar 

Yu X, et al. Cancer epigenetics: from laboratory studies and clinical trials to precision medicine. Cell Death Discov. 2024;10(1):28.

PubMed  PubMed Central  Google Scholar 

Maleknia M, et al. DNA methylation in cancer: epigenetic view of dietary and lifestyle factors. Epigenet Insights. 2023;16:25168657231199892.

PubMed  PubMed Central  Google Scholar 

Rubio K, et al. Nutriepigenomics in environmental-associated oxidative stress. Antioxidants. 2023;12(3):771.

PubMed  PubMed Central  Google Scholar 

Nishiyama A, Nakanishi M. Navigating the DNA methylation landscape of cancer. Trends Genet. 2021;37(11):1012–27.

PubMed  Google Scholar 

Azmi N. Methylation status of potential genes in breast cancer patients and correlate them with gene expression. World J Adv Res Rev. 2023;17(1):815–24.

Google Scholar 

Vuong LD, Nguyen QN. Aberrant methylation of cancer-related genes in vietnamese breast cancer patients: associations with clinicopathological features. Exp Oncol. 2023;45(2):195–202.

Google Scholar 

Ramazi S, et al. Epigenetic regulation in lung cancer. MedComm. 2023;4(6):e401.

PubMed  PubMed Central  Google Scholar 

Hong Y, Kim WJ. DNA methylation markers in lung cancer. Curr Genomics. 2021;22(2):79–87.

PubMed  PubMed Central  Google Scholar 

Chen W-W, et al. Identification of differentially expressed genes induced by aberrant methylation in acute myeloid leukemia using integrated bioinformatics analyses. Oncol Lett. 2022;24(5):1–17.

Google Scholar 

Song P, Wu L, Guan W. Genome-wide identification and characterization of DNA methylation and long non-coding RNA expression in gastric cancer. Front Genet. 2020;11:91.

PubMed  PubMed Central  Google Scholar 

Rauluseviciute I, Drabløs F, Rye MB. DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation. BMC Med Genomics. 2020;13(1):1–15.

Google Scholar 

Ashraf NM, et al. Potential involvement of mi-RNA 574–3p in progression of prostate cancer: a bioinformatic study. Mol Cell Probes. 2017;36:21–8.

PubMed  Google Scholar 

Gong G, Lin T, Yuan Y. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer. J Ovarian Res. 2020;13:1–10.

Google Scholar 

Imran K, et al. Cellular signaling modulated by miRNA-3652 in ovarian cancer: unveiling mechanistic pathways for future therapeutic strategies. Cell Communication and Signaling. 2023;21(1):289.

PubMed  PubMed Central  Google Scholar 

Udali S, et al. DNA methylation and gene expression profiles show novel regulatory pathways in hepatocellular carcinoma. Clin Epigenet. 2015;7(1):1–13.

Google Scholar 

Liang Y, et al. Identification of methylation-regulated differentially expressed genes and related pathways in hepatocellular carcinoma: a study based on TCGA database and bioinformatics analysis. Front Oncol. 2021;11:636093.

PubMed  PubMed Central  Google Scholar 

Sun H, et al. Aberrantly DNA methylated-differentially expressed genes in pancreatic cancer through an integrated bioinformatics approach. Front Genet. 2021;12:583568.

PubMed  PubMed Central  Google Scholar 

Zhang M, et al. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival. Exp Ther Med. 2019;18(3):2140–52.

PubMed  PubMed Central  Google Scholar 

Wang J, et al. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma. J Cell Physiol. 2020;235(2):1296–308.

PubMed  Google Scholar 

Tu Y, et al. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer. J Cell Biochem. 2018;119(11):8797–806.

PubMed  PubMed Central  Google Scholar 

Pramodh S, et al. Luteolin causes 5′ CpG demethylation of the promoters of TSGs and modulates the aberrant histone modifications, restoring the expression of TSGs in human cancer cells. Int J Mol Sci. 2022;23(7):4067.

PubMed  PubMed Central  Google Scholar 

Vanzan L, et al. Mechanisms of histone modifications. In: Tollefsbol T, editor., et al., Handbook of epigenetics. Amsterdam: Elsevier; 2023. p. 27–54.

Google Scholar 

Mortazavi D, et al. Epi-miRNAs: regulators of the histone modification machinery in human cancer. J Oncol. 2022. https://doi.org/10.1155/2022/4889807.

PubMed  PubMed Central  Google Scholar 

Capone V, et al. HAT1: landscape of biological function and role in cancer. Cells. 2023;12(7):1075.

PubMed